Weight Loss by Patiently
US$ 20.25
switching between glp-1 agonists ada receptor in the treatment of type 2 diabetes – state-of-the-art Mapping the effectiveness and risks
Description
Kumaravel A, Zelisko A, Schauer P, Lopez R, Kroh M, Stevens T
10.1016/j.tins.2009.11.003 [DOI] [PMC free article] [PubMed] [Google Scholar] Holscher C
T2D, diabetes mellitus type 2
The first time a clinical outcome was recorded within the above time frame was counted in the analysis
[DOI] [PMC free article] [PubMed] [Google Scholar] 30.Philippe J
